Moulana, Alief http://orcid.org/0000-0002-0389-7082
Dupic, Thomas http://orcid.org/0000-0003-1803-1617
Phillips, Angela M. http://orcid.org/0000-0002-9806-7574
Chang, Jeffrey
Nieves, Serafina http://orcid.org/0000-0002-8670-1814
Roffler, Anne A. http://orcid.org/0000-0001-8412-0322
Greaney, Allison J. http://orcid.org/0000-0001-7202-3349
Starr, Tyler N. http://orcid.org/0000-0001-6713-6904
Bloom, Jesse D. http://orcid.org/0000-0003-1267-3408
Desai, Michael M. http://orcid.org/0000-0002-9581-1150
Funding for this research was provided by:
National Science Foundation (DMS-1764269, PHY-1914916)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM104239)
Article History
Received: 8 September 2022
Accepted: 26 October 2022
First Online: 16 November 2022
Competing interests
: A.M.P. and M.M.D. have or have recently consulted for Leyden Labs. J.D.B. has or has recently consulted for Apriori Bio, Oncorus, Moderna, and Merck. J.D.B., A.J.G., and T.N.S. are inventors on Fred Hutch licensed patents related to viral deep mutational scanning. The other authors declare no competing interests.